⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28483640 | 0.98 | CYP19A1 (0.41) | — | |
| SCHEMBL10065935 | 0.86 | CYP19A1 (0.42) | — | |
| SCHEMBL13872397 | 0.86 | CYP19A1 (0.42) | — | |
| SCHEMBL1345747 | 0.82 | — | — | |
| SCHEMBL15509215 | 0.82 | — | — | |
| SCHEMBL24023176 | 0.82 | — | — | |
| SCHEMBL11969296 | 0.82 | — | — | |
| SCHEMBL20806029 | 0.82 | — | — | |
| SCHEMBL1753748 | 0.82 | CYP19A1 (0.61) | — | |
| SCHEMBL1753962 | 0.82 | GBA1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 187 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105316649-B | The film build method of SiCN film | 东京毅力科创株式会社 | 2018-12-07 | — | — | CN | claimed |
| US-9390907-B2 | Film forming method of SiCN film | TOKYO ELECTRON LIMITED (JP) | 2016-07-12 | — | — | US | claimed |
| US-20150348778-A1 | Film Forming Method of SiCN Film | TOKYO ELECTRON LIMITED (JP) | 2015-12-03 | — | — | US | claimed |
| US-20240067892-A1 | ASSOCIATIVE POLYMERS FOR USE IN A FLOW AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2024-02-29 | — | — | US | disclosed |
| US-20240067892-A1 | ASSOCIATIVE POLYMERS FOR USE IN A FLOW AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2024-02-29 | — | — | US | disclosed |
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | ALPHA-9 ONCOLOGY INC. (CA) | 2024-01-18 | — | — | US | disclosed |
| WO-2023230729-A1 | SYNTHETIC ANTIGEN RECEPTORS FOR COVALENT IMMUNE RECRUITERS AND METHODS AND USES THEREOF | MCMASTER UNIVERSITY (CA) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023141474-A9 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| US-11780849-B2 | Imino sulfanone inhibitors of ENPP1 | VOLASTRA THERAPEUTICS, INC. (US) | 2023-10-10 | — | — | US | disclosed |
| US-11773214-B2 | Multicolored electrochromic polymer compositions and methods of making and using the same | Furcifer Inc. (US) | 2023-10-03 | — | — | US | disclosed |
| EP-4219501-A1 | COMPOUND CONTAINING 2,4-THIAZOLE RING, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | Shandong University (CN) | 2023-08-02 | — | — | EP | disclosed |
| EP-1725544-B1 | 3-[4-HETEROCYCLYL-1,2,3-TRIAZOL-1-YL]-N-ARYL-BENZAMIDES AS INHIBITORS OF THE CYTOKINES PRODUCTION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM PHARMA (US) | 2009-05-27 | — | — | EP | disclosed |
| US-20090111823-A1 | AMINOPYRIDINE DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111854-A1 | 1,2,4-TRIAZOLE ARYL N-OXIDES DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111825-A1 | THIOPHENE 1,2,4-TRIAZOLE DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111824-A1 | AMIDE LINKED HETEROAROMATIC DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | US | disclosed |
| US-20090111811-A1 | 1,2,4-TRIAZOLE CARBOXYLIC ACID DERIVATIVES AS MODULATORS OF MGLUR5 | ASTRAZENECA AB (SE) | 2009-04-30 | — | — | US | disclosed |
| US-20080311136-A1 | Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation | BYONDIS B.V. (NL) | 2008-12-18 | — | — | US | disclosed |
| US-20080227213-A1 | Comprising polymer backbone and two or more pendant RNA binding ligands; myotonic dystrophy | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE | 2008-09-18 | — | — | US | disclosed |
| US-20080160017-A1 | Cross-Linked Antibodies | UCB BIOPHARMA SPRL (BE) | 2008-07-03 | — | — | US | disclosed |